JW Pharma ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About JW Pharma ApS
JW Pharma ApS (CVR number: 39330563) is a company from KØBENHAVN. The company recorded a gross profit of -4.6 kDKK in 2023. The operating profit was -4.6 kDKK, while net earnings were -4.6 kDKK. The profitability of the company measured by Return on Assets (ROA) was -1.1 %, which can be considered poor and Return on Equity (ROE) was -1.5 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -32.2 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. JW Pharma ApS's liquidity measured by quick ratio was 64.2 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | - 125.02 | 69.54 | -33.15 | -7.57 | -4.64 |
EBIT | - 125.02 | 69.54 | -33.15 | -7.57 | -4.64 |
Net earnings | - 125.02 | 69.39 | -35.06 | -9.16 | -4.64 |
Shareholders equity total | - 161.77 | -92.38 | - 127.45 | - 136.61 | - 141.24 |
Balance sheet total (assets) | 452.41 | 346.89 | 311.82 | 302.66 | 298.03 |
Net debt | 399.71 | 194.84 | 229.81 | 238.97 | 243.60 |
Profitability | |||||
EBIT-% | |||||
ROA | -20.3 % | 13.2 % | -7.5 % | -1.7 % | -1.1 % |
ROE | -24.2 % | 17.4 % | -10.6 % | -3.0 % | -1.5 % |
ROI | -20.7 % | 13.5 % | -7.6 % | -1.7 % | -1.1 % |
Economic value added (EVA) | -93.91 | 87.44 | -16.37 | 9.21 | 12.14 |
Solvency | |||||
Equity ratio | -26.3 % | -21.0 % | -29.0 % | -31.1 % | -32.2 % |
Gearing | -367.4 % | -472.2 % | -342.3 % | -319.4 % | -308.9 % |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 11.8 | 80.5 | 68.8 | 65.8 | 64.2 |
Current ratio | 22.8 | 115.6 | 103.9 | 100.9 | 99.3 |
Cash and cash equivalents | 194.61 | 241.43 | 206.46 | 197.30 | 192.67 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | B | BB | BB | BB | BB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.